AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Human trials start on Ebola vaccine.
2003 DEC 10 - (NewsRx.com & NewsRx.net) -- A volunteer has received the first human inoculation of an experimental vaccine designed to prevent infection by Ebola, a highly lethal African virus that some officials fear could be used as a weapon of bioterrorism.
Researchers at the Vaccine Research Center of the National Institute of Allergy and Infectious Diseases, one of the U.S. National Institutes of Health (NIH), administered the vaccine to a volunteer at the NIH clinical center in Bethesda, Maryland, officials announced.
The first human trial comes just 3 years after researchers from the vaccine center announced that an experimental Ebola vaccine had protected monkeys fully from the usually lethal virus.
A part of the experimental vaccine used on monkeys is now being assessed for safety in human volunteers, the NIAID announced. The vaccine is based ...
- NIH begins human Ebola vaccine trial using Biojector 2000.
- Newspaper article from: Vaccine Weekly January 7, 2004 700+ words
...injection systems in VRC-sponsored clinical trials for experimental vaccines against HIV and Ebola. The HIV human clinical trials are currently underway. This article was prepared by Vaccine Weekly editors from staff and other reports.
- Experimental Ebola vaccine given.(Disaster Preparedness)(Vical Inc.,)(Brief...
- Magazine article from: Medical Laboratory Observer January 1, 2004 700+ words
Experimental Ebola vaccine given. An experimental vaccine designed to protect against Ebola...agent. An aerosolized form would be even more deadly. This first Ebola vaccine was made without a single component from the virus itself. Researchers...
- Vical's Ebola vaccine shows early promise.(Brief Article)
- Newspaper article from: Pharma Marketletter February 27, 2006 700+ words
...biophamaceuticals developer, says that a Phase I trial of its leading Ebola vaccine candidate shows that the therapeutic is safe and well-tolerated...favorable regulatory pathway for certain DNA-based products, like its Ebola vaccine.
- Vical and NIH Developing Ebola Vaccine.
- Press release article from: PR Newswire November 18, 2003 700+ words
...Administration (FDA). Human safety testing of the investigational Ebola vaccine also began today using clinical supplies manufactured by...pleased to secure commercialization rights for the VRC's Ebola vaccine as we continue to support its development through optimization...
- Federal Scientists Make Haste in Developing Ebola Vaccine.
- Newspaper article from: Knight Ridder/Tribune Business News November 22, 2001 700+ words
...also are fast-tracking development of the world's first ebola vaccine and should be ready to test it on an initial 20 Americans...he said. And once a company invests the money to make the ebola vaccine, it cannot count on continued long-term production. The...
- Crucell says Ebola vaccine effective on monkeys.(News Wire)
- Magazine article from: Healthcare Purchasing News July 1, 2004 700+ words
Dutch biotechnology firm Crucell said that a single dose of its Ebola vaccine has successfully protected monkeys from the deadly disease in trial tests. Crucell, which used its PER.C6 gene technology to...
- Scientists develop an Ebola vaccine.
- News wire article from: United Press International August 6, 2003 700+ words
...vaccine could be available as soon as 2006. That's a decade sooner than many scientists thought it would take to develop an Ebola vaccine. The work is to be reported in Thursday's edition of the journal Nature. Copyright 2003 by United Press International...
- A New Weapon Against Ebola.(vaccine in development)(Brief Article)
- Magazine article from: Newsweek International Guterl, Fred Suterwalla, Shehnaz December 11, 2000 700+ words
...Maryland. "Does that tell us it will work in humans? No, not yet, but it tells us we're on the right track." An ebola vaccine is an especially tricky thing to develop because the virus is extremely virulent. Researchers had to go down to the Centers...
Source: HighBeam Research, Human trials start on Ebola vaccine.